Q3 2019: Financial Results

Merck KGaA, Darmstadt, Germany generated strong organic sales growth and benefited from positive foreign exchange effects in the third quarter of 2019.


Overview

  • Net sales increase by 8.1%, driven by double-digit growth in Healthcare and Life Science
  • EBITDA pre up by 15.4%
  • Forecast for sales and earnings raised following Versum acquisition

In the third quarter, we continued to resolutely implement our strategy. We substantially increased sales and earnings.

Stefan Oschmann

Chairman of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany

Related News

View All News

Press Releases

Merck KGaA, Darmstadt, Germany Generates Profitable Growth in Q3 2019

Merck KGaA, Darmstadt, Germany generated strong organic sales growth and benefited from positive foreign exchange effects in the third quarter of 2019.

2019/11/14

Gangolf Schrimpf

Financial Communications

Constantin Fest

Head of Investor Relations

Share Price

Our interactive Share Price Tool provides you with all the information you need. You can retrace our development within the last ten years or follow it in real time – or compare our share price to various indices.

Check Share Price

By {{ authorText(item) }}

{{ item.publicationDate }}

Redirect

You have accessed https://www.emdgroup.com, but for users from your part of the world, we originally designed the following web presence https://www.merckgroup.com.

Let's go

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement